AngioDynamics, Inc. (ANGO)

Price$11.94

Value ScoreC

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-13.58%

Price vs S&P 500 (4W)3.26%

VGM Score52.75

Market Capitalization$493.35M

All Metrics

Book Value / Share (Quarterly)$4.16

P/TBV (Annual)3.46x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-2.56%

Cash Flow / Share (Quarterly)$0.04

Price vs S&P 500 (YTD)-17.33%

Gross Margin (TTM)54.30%

Net Profit Margin (TTM)-10.00%

EPS (TTM)$-0.76

10-Day Avg Trading Volume0.30M

EPS Excl Extra (TTM)$-0.76

Revenue Growth (5Y)2.06%

EPS (Annual)$-0.83

ROI (Annual)-17.97%

Gross Margin (Annual)53.92%

Net Profit Margin (5Y Avg)-21.39%

Cash / Share (Quarterly)$0.91

Revenue Growth QoQ (YoY)8.91%

ROA (Last FY)-12.13%

Revenue Growth TTM (YoY)10.73%

EBITD / Share (TTM)$-0.60

ROE (5Y Avg)-27.10%

Operating Margin (TTM)-11.32%

Cash Flow / Share (Annual)$-0.36

P/B Ratio2.85x

P/B Ratio (Quarterly)2.70x

Net Income / Employee (Annual)$-50,400

EV / Revenue (TTM)1.47x

Net Interest Coverage (TTM)-19.15x

ROA (TTM)-11.67%

EV / EBITDA (TTM)54.40x

EPS Incl Extra (Annual)$-0.83

Current Ratio (Annual)2.21x

Quick Ratio (Quarterly)1.26x

3-Month Avg Trading Volume0.39M

52-Week Price Return9.76%

Revenue / Employee (TTM)$464,800

Tangible BV / Share (Quarterly)$2.59

P/S Ratio (Annual)1.69x

Asset Turnover (Annual)1.04x

52-Week High$13.99

Operating Margin (5Y Avg)-22.65%

EPS Excl Extra (Annual)$-0.83

CapEx CAGR (5Y)-10.07%

Tangible BV CAGR (5Y)-15.08%

26-Week Price Return-2.20%

Quick Ratio (Annual)1.30x

13-Week Price Return9.46%

Total Debt / Equity (Annual)0.03x

Current Ratio (Quarterly)2.35x

Enterprise Value$461.44M

Revenue / Share Growth (5Y)0.59%

Asset Turnover (TTM)1.17x

Book Value / Share Growth (5Y)-17.86%

Revenue / Employee (Annual)$433,300

Inventory Turnover (Annual)2.20x

Pretax Margin (Annual)-11.63%

Cash / Share (Annual)$1.36

3-Month Return Std Dev48.63%

Gross Margin (5Y Avg)52.50%

Net Income / Employee (TTM)$-46,500

ROE (Last FY)-18.58%

Net Interest Coverage (Annual)-129.23x

EPS Basic Excl Extra (Annual)$-0.83

P/FCF (TTM)22.15x

Receivables Turnover (TTM)7.05x

EV / Free Cash Flow (TTM)307.01x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.76

Receivables Turnover (Annual)6.76x

ROI (TTM)-17.06%

P/S Ratio (TTM)1.57x

Pretax Margin (5Y Avg)-22.52%

Revenue / Share (Annual)$7.16

Tangible BV / Share (Annual)$2.78

Price vs S&P 500 (52W)-17.28%

Year-to-Date Return-6.31%

5-Day Price Return4.79%

EPS Normalized (Annual)$-0.83

ROA (5Y Avg)-18.08%

Net Profit Margin (Annual)-11.62%

Month-to-Date Return4.79%

Cash Flow / Share (TTM)$0.92

EBITD / Share (Annual)$-0.73

Operating Margin (Annual)-13.66%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)110.91x

ROI (5Y Avg)-26.53%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.76

P/TBV (Quarterly)4.34x

P/B Ratio (Annual)2.15x

Inventory Turnover (TTM)2.36x

Pretax Margin (TTM)-10.00%

Book Value / Share (Annual)$4.46

Price vs S&P 500 (13W)-1.04%

Beta0.33x

P/FCF (Annual)26.10x

Revenue / Share (TTM)$7.54

ROE (TTM)-17.65%

52-Week Low$8.36

vGradeC

gGradeC

mGradeB

vgmGradeC

Show chart for

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.20

4.18

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
ANGOAngioDynamics, Inc.	C	C	B	$11.94
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

AngioDynamics Inc develops and manufactures specialized medical devices for treating peripheral vascular disease and supporting oncology and surgical procedures. The company generates the majority of its revenue from sales to U.S. healthcare providers.